Literature DB >> 8141582

In vitro selection of human rhinovirus relatively resistant to soluble intercellular adhesion molecule-1.

E Arruda1, C E Crump, F G Hayden.   

Abstract

Variants of human rhinovirus serotype 39 (HRV-39) relatively resistant to inhibition by soluble intercellular adhesion molecule-1 (sICAM-1) were selected by serial passages in HeLa or WI-38 cells in the presence of sICAM-1. Moderate resistance (four- to fivefold increases in 50% effective inhibitory concentrations [EC50s]) was observed after the second passage in HeLa cells and remained constant during six further passages in the presence of 10 micrograms of sICAM-1 per ml. A 7- to 17-fold increase in EC50s was observed in WI-38 cells during passage with 10 micrograms/ml, and reversion to a nonresistant phenotype was not observed after four passages in the absence of sICAM-1. Resistance of a higher degree was obtained by passing HRV-39 in the presence of 100 micrograms of sICAM-1 per ml in HeLa cells (30-fold EC50 increase). The sICAM-1-resistant phenotype was estimated to constitute 1 in 10(4) to 1 in 10(5) PFU of a nonexposed HRV-39 population. Low to moderate levels of resistance to sICAM-1 inhibition emerge readily during in vitro passage in the presence of sICAM-1 and appear to be phenotypically stable.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8141582      PMCID: PMC284398          DOI: 10.1128/AAC.38.1.66

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

1.  Studies of rhinovirus resistant to an antiviral chalcone.

Authors:  A L Ahmad; A B Dowsett; D A Tyrrell
Journal:  Antiviral Res       Date:  1987-08       Impact factor: 5.970

2.  Evidence for the direct involvement of the rhinovirus canyon in receptor binding.

Authors:  R J Colonno; J H Condra; S Mizutani; P L Callahan; M E Davies; M A Murcko
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

3.  Evidence for at least two dominant neutralization antigens on human rhinovirus 14.

Authors:  B Sherry; R Rueckert
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

4.  Mechanisms of receptor-mediated rhinovirus neutralization defined by two soluble forms of ICAM-1.

Authors:  J M Greve; C P Forte; C W Marlor; A M Meyer; H Hoover-Litty; D Wunderlich; A McClelland
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

5.  Formation of rhinovirus-soluble ICAM-1 complexes and conformational changes in the virion.

Authors:  H Hoover-Litty; J M Greve
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

6.  Identification of monoclonal antibody epitopes and critical residues for rhinovirus binding in domain 1 of intercellular adhesion molecule 1.

Authors:  A McClelland; J deBear; S C Yost; A M Meyer; C W Marlor; J M Greve
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

7.  The major human rhinovirus receptor is ICAM-1.

Authors:  J M Greve; G Davis; A M Meyer; C P Forte; S C Yost; C W Marlor; M E Kamarck; A McClelland
Journal:  Cell       Date:  1989-03-10       Impact factor: 41.582

8.  A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses.

Authors:  D E Staunton; V J Merluzzi; R Rothlein; R Barton; S D Marlin; T A Springer
Journal:  Cell       Date:  1989-03-10       Impact factor: 41.582

9.  Induction of intercellular adhesion molecule 1 on primary and continuous cell lines by pro-inflammatory cytokines. Regulation by pharmacologic agents and neutralizing antibodies.

Authors:  R Rothlein; M Czajkowski; M M O'Neill; S D Marlin; E Mainolfi; V J Merluzzi
Journal:  J Immunol       Date:  1988-09-01       Impact factor: 5.422

10.  In vitro activity of R 61837, a new antirhinovirus compound.

Authors:  K Andries; B Dewindt; M De Brabander; R Stokbroekx; P A Janssen
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

View more
  4 in total

1.  Failure to block adhesion of Plasmodium falciparum-infected erythrocytes to ICAM-1 with soluble ICAM-1.

Authors:  A G Craig; R Pinches; S Khan; D J Roberts; G D Turner; C I Newbold; A R Berendt
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

Review 2.  Problems and prospects of developing effective therapy for common cold viruses.

Authors:  S L Johnston
Journal:  Trends Microbiol       Date:  1997-02       Impact factor: 17.079

3.  Comparative antirhinoviral activities of soluble intercellular adhesion molecule-1 (sICAM-1) and chimeric ICAM-1/immunoglobulin A molecule.

Authors:  C E Crump; E Arruda; F G Hayden
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

Review 4.  The treatment of rhinovirus infections: progress and potential.

Authors:  R B Turner
Journal:  Antiviral Res       Date:  2001-01       Impact factor: 5.970

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.